The Latest Cardiac and Vascular News
Opportunities Featuring Proprietary Surface Coated Technologies CARLSBAD, Calif., April 7, 2022 /PRNewswire/ — CeloNova BioSciences, Inc. (CeloNova), developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene™-F nanocoating, today announced the strategic decision to focus its core business on creating partnership and co-development opportunities with medical device manufacturers seeking […]
Positive results from the landmark PzF SHIELD IDE clinical trial reinforce safe and effective use in a real-world clinical practice of the world’s first non-drug-eluting, nanocoated coronary stent. SAN ANTONIO, May 13, 2021 /PRNewswire/ — CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its […]
